Effective dose against LPS-stimulated Tumor necrosis factor, alpha release in mice dosed orally, 30 min prior to LPS challenge (0.1 mg/kg, ip); ND is No Data
Effective dose against LPS-stimulated Tumor necrosis factor, alpha release in mice dosed orally, 30 min prior to LPS challenge (0.1 mg/kg, ip); ND is No Data.
Effective dose against LPS-stimulated Tumor necrosis factor, alpha release in mice dosed orally, 30 min prior to LPS challenge (0.1 mg/kg, ip); value ranges from 3-10
Inhibition of TNF-alpha in mouse RAW264.7 cells assessed as inhibition of LPS-induced IKBalpha phosphorylation at 5 to 20 uM pre-incubated for 12 hrs before LPS stimulation for 2 hrs by Western blot analysis
Inhibition of TNF-alpha in mouse RAW264.7 cells assessed as inhibition of LPS-induced IKBalpha phosphorylation at 5 to 20 uM pre-incubated for 12 hrs before LPS stimulation for 2 hrs by Western blot analysis
Inhibition of TNF-alpha in mouse RAW264.7 cells assessed as inhibition of NFkappB/p65 nuclear translocation at 5 to 20 uM by DAPI staining based microscopy